ArticleAntimicrobial agents and chemotherapy2026
Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant
William C Shropshire et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.